Addressing scabies, the neglected of neglected disease

June 18, 2016

Medicines Development for Global Health has received AU$1.5 million from the Australian Tropical Medicines Commercialisation fund with matching funding from the Global Health Investment Fund for a total of AU$3 million to used to run a pivotal Phase II dose finding trial for moxidectin for scabies elimination.

Read MDL press release..